Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gollerkeri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|June 8, 2001
Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experienceA Gollerkeri, L Harrold, M Rose, et al.
Journal of General Internal Medicine|March 1, 1996
A study of cross-coverage callsB Ramratnam, A Gollerkeri, P Martens, et al.
British Journal of Haematology|September 1, 1995
Management of persistent B19 parvovirus infection in AIDSB Ramratnam, A Gollerkeri, F J Schiffman, et al.
Cancer Metastasis Reviews|February 8, 2002
Translational regulation as a novel mechanism for the development of cellular drug resistanceJ C Schmitz, J Liu, X Lin, et al.
Bone Marrow Transplantation|August 5, 2000
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular functionM Rose, F A Lee, A Gollerkeri, et al.
The Yale Journal of Biology and Medicine|October 20, 1999
Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimenJ R Murren, A Gollerkeri, S Anderson, et al.
Cancer|September 15, 1996
p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinomaH Safran, T King, H Choy, et al.
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|June 8, 2001
Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experienceA Gollerkeri, L Harrold, M Rose, et al.
Journal of General Internal Medicine|March 1, 1996
A study of cross-coverage callsB Ramratnam, A Gollerkeri, P Martens, et al.
British Journal of Haematology|September 1, 1995
Management of persistent B19 parvovirus infection in AIDSB Ramratnam, A Gollerkeri, F J Schiffman, et al.
Cancer Metastasis Reviews|February 8, 2002
Translational regulation as a novel mechanism for the development of cellular drug resistanceJ C Schmitz, J Liu, X Lin, et al.
Bone Marrow Transplantation|August 5, 2000
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular functionM Rose, F A Lee, A Gollerkeri, et al.
The Yale Journal of Biology and Medicine|October 20, 1999
Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimenJ R Murren, A Gollerkeri, S Anderson, et al.
Cancer|September 15, 1996
p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinomaH Safran, T King, H Choy, et al.
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
Pageof 1